| Study title |
A Double-blind, Randomized, Placebo-Controlled Study and Open-label Long Term Extension to evaluate efficacy and safety of Elafibranor 80 mg in Patients with Primary Biliary Cholangitis with Inadequate Response or Intolerance to Ursodeoxycholic Acid |
| Disease or condition |
Primary biliary cholangitis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Elafibrinor or placebo |
| Phase |
3 |
| Study site |
Duke University |
| Study location |
Durham |
| Principal investigator name and email |
Andrew Muir, andrew.muir@duke.edu |
| Study coordinator name and email |
Christy Walters, christy.walters@duke.edu |
| Phone contact |
919-668-5499 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04526665 |
